Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;138(8):1421-5.
doi: 10.1007/s00432-012-1211-5. Epub 2012 Apr 18.

EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma

Affiliations

EGFR L861Q mutation is a frequent feature of pulmonary mucoepidermoid carcinoma

Yongfeng Yu et al. J Cancer Res Clin Oncol. 2012 Aug.

Abstract

Purpose: The purpose of this study is to assess the feasibility of targeted treatment for pulmonary mucoepidermoid carcinoma (PMEC) by investigating track record of the epidermal growth factor receptor (EGFR) mutation status in PMEC.

Methods: From January 2001 to December 2009, 20 PMEC patients (11 males and 9 females) received treatment in our center. All the patients received surgery and were diagnosed by pathology. Sequencing analysis was used to monitor exons 18-21 of the EGFR gene mutation.

Results: The exon 21 L861Q heterozygous mutation was confirmed in five patients. There was no case with any deletion in exon 19 or exon 21 L858R mutation. One case was with a homonymy exon 18 mutation (I760I). Exon 20 G2607A (Q787Q) SNP was found in 12 of those 20 patients.

Conclusion: L861Q mutation in exon 21 is the most frequent feature of heterozygous mutation in our study. Further investigations will be required to validate our findings.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hematoxylin and eosin staining (×100) showing PMEC with low grade of pathological diagnosis in patient 20
Fig. 2
Fig. 2
Sequencing analysis result of patient 3 showing exon 21 L861Q heterozygous mutation (forward 184 T—A, reverse 51 A—T)

References

    1. Chin CH, Huang CC, Lin MC, Chao TY, Liu SF (2008) Prognostic factors of tracheobronchial mucoepidermoid carcinoma-15 years experience. Respirology 13:275–280 - PubMed
    1. Dahse R, Driemel O, Schwarz S, Dahse J, Kromeyer-Hauschild K, Berndt A, Kosmehl H (2009) Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas. Br J Cancer 100:623–625 - PMC - PubMed
    1. Han SW, Kim HP, Jeon YK, Oh DY, Lee SH, Kim DW et al (2008) Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment. Lung Cancer 61:30–34 - PubMed
    1. Heitmiller RF, Mathisen DJ, Ferry JA, Mark EJ, Grillo HC (1989) Mucoepidermoid lung tumors. Ann Thorac Surg 47:394–399 - PubMed
    1. Kang DY, Yoon YS, Kim HK, Choi YS, Kim K, Shim YM, Kim J (2011) Primary salivary gland-type lung cancer: surgical outcomes. Lung Cancer 72:250–254 - PubMed

MeSH terms